The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention
Open accessAbstract
Fragility fractures are common, affecting almost one in two older women and one in three older men. Every fragility fracture signals increased risk of future fractures as well as risk of premature mortality. Despite the major health care impact worldwide, currently there are few systems in place to identify and “capture” individuals after a fragility fracture to ensure appropriate assessment and treatment (according to national guidelines) to reduce future fracture risk and adverse health outcomes. The Task Force reviewed the current evidence about different systematic interventional approaches, their logical background, as well as the medical and ethical rationale. This included reviewing the evidence supporting cost-effective interventions and developing a toolkit for reducing secondary fracture incidence. This report presents this evidence for cost-effective interventions versus the human and health care costs associated with the failure to address further fractures. In particular, it summarizes the evidence for various forms of Fracture Liaison Service as the most effective intervention for secondary fracture prevention. It also summarizes the evidence that certain interventions, particularly those based on patient and/or community-focused educational approaches, are consistently, if unexpectedly, ineffective. As an international group, representing 36 countries throughout Asia-Pacific, South America, Europe, and North America, the Task Force reviewed and summarized the international data on barriers encountered in implementing risk-reduction strategies. It presents the ethical imperatives for providing quality of care in osteoporosis management. As part of an implementation strategy, it describes both the quality improvement methods best suited to transforming care and the research questions that remain outstanding. The overarching outcome of the Task Force's work has been the provision of a rational background and the scientific evidence underpinning secondary fracture prevention and stresses the utility of one form or another of a Fracture Liaison Service in achieving those quality outcomes worldwide. © 2012 American Society for Bone and Mineral Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Self-citationOnce-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,289
Klotzbuecher, C. M., Ross, P. D., Landsman, P. B., Abbott, T. A., & Berger, M. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.721 · Cited by 2,023
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003
Effect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
Cited by
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Self-citationOsteoporosis treatment: recent developments and ongoing challenges
Khosla, S., & Hofbauer, L. C. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30188-2 · Cited by 1,019
Miller, P. D., Hattersley, G., Riis, B. J., Williams, G. C., Lau, E., Russo, L. A., Alexandersen, P., Zerbini, C. A. F., Hu, M.-Y., Harris, A. G., et al. (2016) · JAMA · doi:10.1001/jama.2016.11136 · Cited by 875
Eastell, R., O'Neill, T. W., Hofbauer, L. C., Langdahl, B., Reid, I. R., Gold, D. T., & Cummings, S. R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.69 · Cited by 827
Adler, R. A., El-Hajj Fuleihan, G., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J., Favus, M. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2708 · Cited by 672
Self-citationIOF Fracture Working Group, Åkesson, K., Marsh, D., Mitchell, P. J., McLellan, A. R., Stenmark, J., Pierroz, D. D., Kyer, C., & Cooper, C. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2348-z · Cited by 521
Self-citationOsteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011
Solomon, D. H., Johnston, S. S., Boytsov, N. N., McMorrow, D., Lane, J. M., & Krohn, K. D. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2202 · Cited by 368
Impact of hip fracture on hospital care costs: a population-based study
The REFReSH study group, Leal, J., Gray, A. M., Prieto-Alhambra, D., Arden, N. K., Cooper, C., Javaid, M. K., & Judge, A. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3277-9 · Cited by 355
Singer, A., Exuzides, A., Spangler, L., O’Malley, C., Colby, C., Johnston, K., Agodoa, I., Baker, J., & Kagan, R. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.09.011 · Cited by 339
Immunoporosis: Immunology of Osteoporosis—Role of T Cells
Srivastava, R. K., Dar, H. Y., & Mishra, P. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00657 · Cited by 331
The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide
Curtis, E. M., Moon, R. J., Harvey, N. C., & Cooper, C. (2017) · Bone · doi:10.1016/j.bone.2017.01.024 · Cited by 330
A Crisis in the Treatment of Osteoporosis
Khosla, S., & Shane, E. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2888 · Cited by 319
Wu, C.-H., Tu, S.-T., Chang, Y.-F., Chan, D.-C., Chien, J.-T., Lin, C.-H., Singh, S., Dasari, M., Chen, J.-F., & Tsai, K.-S. (2018) · Bone · doi:10.1016/j.bone.2018.03.018 · Cited by 307
Glutamine Metabolism Regulates Proliferation and Lineage Allocation in Skeletal Stem Cells
Yu, Y., Newman, H., Shen, L., Sharma, D., Hu, G., Mirando, A. J., Zhang, H., Knudsen, E., Zhang, G.-F., Hilton, M. J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.016 · Cited by 253
Weitzmann, M. N. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 259
Zhou, T., Yang, Y., Chen, Q., & Xie, L. (2019) · Stem Cells International · doi:10.1155/2019/8928934 · Cited by 73
Bone densitometry worldwide: a global survey by the ISCD and IOF
on behalf of the International Society for Clinical Densitometry (ISCD) and the International Osteoporosis Foundation (IOF), Clynes, M. A., Westbury, L. D., Dennison, E. M., Kanis, J. A., Javaid, M. K., Harvey, N. C., Fujita, M., Cooper, C., Leslie, W. D., et al. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05435-8 · Cited by 64
The REFReSH study group, Drew, S., Judge, A., May, C., Farmer, A., Cooper, C., Javaid, M. K., & Gooberman-Hill, R. (2015) · Implementation Science · doi:10.1186/s13012-015-0243-z · Cited by 43
Metadata
- Authors
- Eisman, J. A., Bogoch, E. R., Dell, R., Harrington, J. T., McKinney, R. E., McLellan, A., Mitchell, P. J., Silverman, S., Singleton, R., Siris, E., & for the ASBMR Task Force on Secondary Fracture Prevention
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-07-26
- Volume
- 27
- Issue
- 10
- Pages
- 2039-2046
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2009699689
- Cited by
- 383
- References
- 39
- FWCI
- 28.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.